This transcription factor controls the expression of numerous genes involved in antigen presentation, including class I and II MHC molecules, which display tumor or pathogen derived peptides to killer T cells (CD4+/CD8+; LeibundGut-Landmann et al., 2004). The gene discussed is CD8A; the disease is neoplasm.